Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 1
2(33.3%)
6Total
N/A(4)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT01401751Not ApplicableCompleted

Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting

Role: lead

NCT00922649Not ApplicableCompleted

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Role: lead

NCT01919385Phase 1Completed

Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia

Role: lead

NCT00874809Not ApplicableCompleted

Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study

Role: collaborator

NCT01638299Phase 1Completed

Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC Setting

Role: lead

NCT01401127Completed

Managing Insulin Pumps for Exercise - Study 1

Role: collaborator

NCT01398995Not ApplicableTerminated

Managing Insulin Pumps for Exercise (Study 2)

Role: collaborator

All 7 trials loaded